Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody

被引：14

作者：

Akaishi, Tetsuya ^{[1
,2
]}

Fujimori, Juichi ^{[3
]}

Takahashi, Toshiyuki ^{[1
,4
]}

Misu, Tatsuro ^{[1
]}

Takai, Yoshiki ^{[1
]}

Nishiyama, Shuhei ^{[1
]}

Kaneko, Kimihiko ^{[1
]}

Ogawa, Ryo ^{[1
]}

Abe, Michiaki ^{[2
]}

Ishii, Tadashi ^{[2
]}

Aoki, Masashi ^{[1
]}

Fujihara, Kazuo ^{[5
]}

Nakashima, Ichiro ^{[3
]}

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan

[2] Tohoku Univ Hosp, Dept Educ & Support Reg Med, Sendai, Miyagi, Japan

[3] Tohoku Med & Pharmaceut Univ, Dept Neurol, Sendai, Miyagi, Japan

[4] Natl Hosp Org Yonezawa Natl Hosp, Dept Neurol, Yonezawa, Yamagata, Japan

[5] Fukushima Med Univ, Dept Multiple Sclerosis Therapeut, Fukushima, Japan

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2020年 / 349卷

关键词：

Aquapotin-4; Attacks; Myelin-oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorders; Seasonal distribution; EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; RISK;

D O I：

10.1016/j.jneuroim.2020.577431

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This study aimed to determine the seasonal impact on the clinical onset of inflammatory neurological diseases of the central nervous system by analyzing the onset month with information on clinical manifestations in Japanese patients. As a result, patients with anti-aquaporin-4 antibodies (AQP4-IgG)-positive neuromyelitis optica spec-trum disorders (NMOSD) showed spring-summer predominance of the clinical onset. Conversely, patients with anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease showed autumn-winter predominance of the clinical onset. Both seasonal variations were irrespective of the clinical manifestation. Environmental factors with seasonal variation influence the development of neurological conditions related to AQP4-IgG and MOG-IgG.

引用

页数：5

共 50 条

[41] Autoimmune cortical encephalitis in two children with anti-myelin oligodendrocyte glycoprotein (MOG) antibody
D. Doig
C. McNamara
L. Mewasingh
S. Beri
B. Jones
C. Kachramanoglou
W. Jan
Journal of Neurology, 2021, 268 : 1096 - 1101
[42] Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
Waters, Patrick
Fadda, Giulia
Woodhall, Mark
O'Mahony, Julia
Brown, Robert A.
Castro, Denise A.
Longoni, Giulia
Irani, Sarosh R.
Sun, Bo
Yeh, E. Ann
Marrie, Ruth Ann
Arnold, Douglas L.
Banwell, Brenda
Bar-Or, Amit
Awuku, Mark
Baird, J. Burke
Bhan, Virender
Buckley, David
Callen, David
Connolly, Mary B.
Dilenge, Marie-Emmanuelle
Doja, Asif
Levin, Simon
Lortie, Anne
MacDonald, E. Athen
Mah, Jean K.
Meaney, Brandon
Meek, David
Pohl, Daniela
Sebire, Giullaume
Venkateswaran, Sunita
Waldman, Amy
Wambera, Katherine
Wood, Ellen
Yager, Jerome
JAMA NEUROLOGY, 2020, 77 (01) : 82 - 93
[43] Analysis of anti-myelin oligodendrocyte glycoprotein (MOG) antibody in patients with multiple sclerosis (MS) and its significance
Gao, F
Li, QY
Hao, HJ
Yun, JM
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 609 - 609
[44] Anti-myelin Oligodendrocyte Glycoprotein Presentation In 2 Latina Women
Christiana, A.
Hernandez-Peraza, Z.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 70 - 71
[45] Recurrent lobar encephalitis with epilepsy with positive anti-myelin oligodendrocyte glycoprotein and anti-glutamate receptor antibodies
Sakurai, Yasuhisa
Yashita, Daiki
Komaki, Shogo
Hao, Akihito
Uchio, Naohiro
Matsumoto, Hideyuki
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (04): : 231 - 232
[46] ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY ASSOCIATED MYELITIS IN A 4-YEAR-OLD FEMALE WITH HUMAN METAPNEUMOVIRUS
Prudencio, S.
Sharma, P.
Irazuzta, J.
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 630 - 630
[47] Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019
Uchino, Kenji
Soga, Kaima
Shinohara, Kensuke
Imai, Takeshi
Motohashi, Iori
Okuma, Hirohisa
Yamano, Yoshihisa
INTERNAL MEDICINE, 2023, 62 (10) : 1531 - 1535
[48] A unique case with positive anti-myelin oligodendrocyte glycoprotein antibody presenting multiple brain lesions
Matsumoto, Namiko
Sato, Kota
Hishikawa, Nozomi
Kawahara, Yuko
Takemoto, Mami
Ohta, Yasuyuki
Yamashita, Toru
Fujii, Kentaro
Kurozumi, Kazuhiko
Date, Isao
Takahashi, Toshiyuki
Abe, Koji
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (02): : 92 - 95
[49] The Relationship between Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and the Rubella Virus
Choi, Seok-Jin
Oh, Dan A.
Chun, Woochang
Kim, Sung-Min
JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (04): : 598 - 600
[50] Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in a Patient with Ataxia, Diplopia, and an Enhancing Cerebellar Lesion
Gutman, Josef
Fouladvand, Mohammad
Jafar, Jafar
Jain, Rajan
Kister, Ilya
NEUROLOGY, 2018, 90

← 1 2 3 4 5 →